Bemiparin
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Bemiparin is an antithrombotic and belongs to the group of low molecular weight heparins (LMWH).[1]
Like semuloparin, bemiparin is classified as an ultra-LMWH because of its low molecular mass of 3600 Daltons on average. (Enoxaparin has 4500 Daltons.) These heparins have lower anti-thrombin activity than classical LMWHs and act mainly on factor Xa, reducing the risk of bleeding.
External Links
External Links
- Chapman TM, Goa KL (2003). “Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis”. Drugs. 63 (21): 2357–77. PMID 14524738.
- bemiparin at the US National Library of Medicine Medical Subject Headings (MeSH)
References
References
- ↑ Chapman TM, Goa KL (2003). “Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis”. Drugs. 63 (21): 2357–77. doi:10.2165/00003495-200363210-00009. PMID 14524738.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH